Evidence map›Paper›PMID 35161878›Full record

ArticleSensors (Basel, Switzerland)2022

Melanoma Classification Using a Novel Deep Convolutional Neural Network with Dermoscopic Images.

Ranpreet Kaur, Hamid GholamHosseini, Roopak Sinha, Maria Lindén

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Deep Learning Approach for Biomedical Image Classification.Journal of imaging informatics in medicine · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ranpreet KaurSchool of Engineering, Computer and Mathematical Sciences, Auckland University of Technology, Auckland 1010, New Zealand.ORCID 0000-0003-0741-2377
Hamid GholamHosseiniSchool of Engineering, Computer and Mathematical Sciences, Auckland University of Technology, Auckland 1010, New Zealand.ORCID 0000-0002-0135-2687
Roopak SinhaSchool of Engineering, Computer and Mathematical Sciences, Auckland University of Technology, Auckland 1010, New Zealand.ORCID 0000-0001-9486-7833
Maria LindénSchool of Innovation, Design and Engineering, Mälardalen University, 722 20 Västerås, Sweden.ORCID 0000-0003-1940-1747

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Automatic melanoma detection from dermoscopic skin samples is a very challenging task. However, using a deep learning approach as a machine vision tool can overcome some challenges. This research proposes an automated melanoma classifier based on a deep convolutional neural network (DCNN) to accurately classify malignant vs. benign melanoma. The structure of the DCNN is carefully designed by organizing many layers that are responsible for extracting low to high-level features of the skin images in a unique fashion. Other vital criteria in the design of DCNN are the selection of multiple filters and their sizes, employing proper deep learning layers, choosing the depth of the network, and optimizing hyperparameters. The primary objective is to propose a lightweight and less complex DCNN than other state-of-the-art methods to classify melanoma skin cancer with high efficiency. For this study, dermoscopic images containing different cancer samples were obtained from the International Skin Imaging Collaboration datastores (ISIC 2016, ISIC2017, and ISIC 2020). We evaluated the model based on accuracy, precision, recall, specificity, and F1-score. The proposed DCNN classifier achieved accuracies of 81.41%, 88.23%, and 90.42% on the ISIC 2016, 2017, and 2020 datasets, respectively, demonstrating high performance compared with the other state-of-the-art networks. Therefore, this proposed approach could provide a less complex and advanced framework for automating the melanoma diagnostic process and expediting the identification process to save a life.

Indexed as

MelanomaSkin NeoplasmsDermoscopyHumansNeural Networks, ComputerSkinclassificationdeep convolutional neural networksmelanomaskin cancer

Identifiers

PMID35161878
PMCPMC8838143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.